Cetuximab

Cetuximab is a monoclonal antibody medication used for the treatment of specific types of cancer. It is used primarily for the treatment of metastatic colorectal cancer and head and neck cancer that has progressed following prior treatment. Cetuximab works by binding to epidermal growth factor receptor (EGFR) on the surface of cancer cells, which helps to inhibit the growth and spread of these cells.
Cetuximab is administered through intravenous infusion, usually every week or two, depending on the condition being treated. The medication may be given alone or in combination with other therapies, such as chemotherapy or radiotherapy. It is important for patients to discuss their treatment plan and possible side effects with their healthcare provider before beginning cetuximab therapy.
Common side effects of cetuximab include skin reactions, such as acne-like rash, pain at the injection site, and mouth sores. Less common side effects may include nausea, diarrhea, and changes in taste or smell. In some cases, patients may experience more severe side effects, such as inflammation of the lungs or severe skin reactions. It is important for patients to report any new or worsening symptoms to their healthcare provider promptly.